Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection Due to the Potential for Glass Particulate

July 2, 2019

Fresenius Kabi USA, LLC is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the potential for glass particulate. 

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection

May 3, 2019

FDA Alerts Providers and Patients to Check for Premature Battery Depletion in Certain Medtronic Pacemakers

May 7, 2019

Quarterly Update to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS)

April 26, 2019

Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal

APRIL 19, 2019

FDA MedWatch: Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets

November 30, 2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets

 

FDA MedWatch: SGLT2(sodium-glucose cotransporter-2) Inhibitors for Diabetes: Drug Safety Communication

August 30, 2018

FDA MedWatch: Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 Mg Due to Labeling Mix-up

August 30, 2018

Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 – 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.

FDA MedWatch Class 2 Device Recall: AMIA Automated PD Cycler

Date Initiated by Firm

July 12, 2018

Create Date

August 02, 2018

Pages